Literature DB >> 12106535

[Prevalence of vitamin D deficiency in populations at risk for osteoporosis: impact on bone integrity].

Pedro Mezquita Raya1, Manuel Muñoz Torres, Francisca López Rodríguez, Nuria Martínez Martín, Alicia Conde Valero, Norberto Ortego Centeno, Jorge González Calvín, Enrique Raya Alvarez, Juan de Dios Luna Jd, Fernando Escobar Jiménez.   

Abstract

BACKGROUND: Nowadays, severe deficiency of vitamin D is not a common finding in most developed countries. However, the prevalence of vitamin D insufficiency is relatively high and it can contribute to the descent of bone mass in osteoporosis risk populations. The objective of our study was to evaluate the prevalence of vitamin D insufficiency in postmenopausal women (PMW), patients with inflammatory bowel disease (IBD) and corticosteroid-dependent asthmatic patients (CAP) and to analyze its relationship with bone mineral density (BMD) and calciotropic hormones. PATIENTS AND
METHOD: We studied 299 patients (PMW: 161; IBD: 61; CAP: 77). In all cases, serum levels of PTH and 25OHD were determined and the BMD (DXA, Hologic QDR1000) in lumbar spine (LS) and femoral neck (FN) was measured.
RESULTS: Vitamin D insufficiency (25OHD < 15 ng/ml) was observed in 39.1% patients with PMW, 70.7% patients with IBD and 44.2% patients with CAP. 25OHD concentrations were lower in EII patients (p = 0.003) and PTH concentrations were higher in MPM (p < 0.001). We found a negative correlation between PTH and 25OHD in the overall group and this correlation persisted after considering each group separately. After adjusting for remaining variables, 25OHD was found to be significantly associated with BMD at lumbar spine and/or femoral neck in the three groups.
CONCLUSIONS: In populations at risk of osteoporosis, there is a high prevalence of vitamin D insufficiency. This insufficiency has a significant effect on bone integrity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12106535     DOI: 10.1016/s0025-7753(02)73327-7

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  6 in total

1.  Vitamin D status in children and young adults with inflammatory bowel disease.

Authors:  Helen M Pappa; Catherine M Gordon; Tracee M Saslowsky; Anna Zholudev; Brian Horr; Mei-Chiung Shih; Richard J Grand
Journal:  Pediatrics       Date:  2006-11       Impact factor: 7.124

2.  Determinant factors of osteoporosis patients' reported therapeutic adherence to calcium and/or vitamin D supplements: a cross-sectional, observational study of postmenopausal women.

Authors:  José Sanfelix-Genovés; Vicente F Gil-Guillén; Domingo Orozco-Beltran; Vicente Giner-Ruiz; Salvador Pertusa-Martínez; Begoña Reig-Moya; Concepción Carratalá
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

Review 3.  Vitamin D status in gastrointestinal and liver disease.

Authors:  Helen M Pappa; Elana Bern; Daniel Kamin; Richard J Grand
Journal:  Curr Opin Gastroenterol       Date:  2008-03       Impact factor: 3.287

4.  Treatment of eggshell with casein phosphopeptide reduces the severity of ovariectomy-induced bone loss.

Authors:  Jung-Hoon Kim; Min Seuk Kim; Hong-Geun Oh; Hak-Yong Lee; Jeong-Woo Park; Bong-Gun Lee; Sang-Hoon Park; Dae-In Moon; Eun-Hye Shin; Eun-Kyeong Oh; Munkhsoyol Erkhembaatar; Okjin Kim; Yong-Rae Lee; Han-Jung Chae
Journal:  Lab Anim Res       Date:  2013-06-24

5.  Oral Calcidiol Is More Effective Than Cholecalciferol Supplementation to Reach Adequate 25(OH)D Levels in Patients with Autoimmune Diseases Chronically Treated with Low Doses of Glucocorticoids: A "Real-Life" Study.

Authors:  Miguel Ortego-Jurado; José-Luis Callejas-Rubio; Raquel Ríos-Fernández; Juan González-Moreno; Amanda Rocío González Ramírez; Miguel A González-Gay; Norberto Ortego-Centeno
Journal:  J Osteoporos       Date:  2015-06-01

6.  The importance of vitamin D in the pathology of bone metabolism in inflammatory bowel diseases.

Authors:  Iwona Krela-Kaźmierczak; Aleksandra Szymczak; Liliana Łykowska-Szuber; Piotr Eder; Kamila Stawczyk-Eder; Katarzyna Klimczak; Krzysztof Linke; Wanda Horst-Sikorska
Journal:  Arch Med Sci       Date:  2015-10-12       Impact factor: 3.318

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.